GLMD News and Press, Galmed Pharmaceuticals Ltd. From 03/20/25

Galmed Pharmaceuticals Secures New Patent Grant Extending Aramchol's Patent Protection to 2039, Strengthening Leadership in NASH/MASH Combination Therapy PR Newswire TEL AVIV, Israel , March 20, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD)...

2025-03-17 12:06:54 ET Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) is one of today’s top gainers. The company’s shares have moved 40.14% on the day to $2.42. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeut...